Director Shareholding

| Filed in:
Tate & Lyle PLC announces a grant of options under the Tate & Lyle 2001 Sharesave Scheme. The date of grant is 5 December 2006 and the option price is 716 pence per share. The options granted are normally exercisable during the period from 1 March 2010 to 31 August 2010. Grants were made to two executive directors of Tate & Lyle PLC as detailed below. A grant of 1,319 options was made to John Nicholas. Following this transaction, Mr Nicholas now holds options over 71,221 ordinary shares in Tate & Lyle PLC. A grant of 263 options was made to Stuart Strathdee. Following this transaction, Mr Strathdee now holds options over 449,491 ordinary shares in Tate & Lyle PLC. The notification of these transactions is intended to satisfy the Company’s obligations under both section 324 Companies Act 1985 and Disclosure Rule 3.1.2.

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.  

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 39 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2024, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2023, revenue for the enlarged Tate & Lyle Group would have been £2.25 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube